Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

These gene variations are not linked to alopecia areata in Egyptians.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

IL-15 promotes hair growth and protects hair follicles.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Alopecia areata severity is linked to increased TH1 and TH2 activity.